logo
Select company
Select metric
11.9%Goodwill & Intangibles to Assets Ratio
VS
Market
63
Sector
68
Industry
86
History
95
$ 1.65Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information

Ticker

CHRS

Company Name

COHERUS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

COHERUS ONCOLOGY INC - Goodwill & Intangibles to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CHRS - Intang. to Assets Historical data
DateTotal AssetsGoodwill and IntangiblesGoodwill & Intangibles to Assets Ratio
6/30/2025$ 439.46M$ 52.31M11.9%
3/31/2025$ 371.07M$ 52.98M14.28%
12/31/2024$ 448.53M$ 53.65M11.96%
9/30/2024$ 505M$ 54.31M10.76%
6/30/2024$ 674.86M$ 55.45M8.22%
3/31/2024$ 763.54M$ 57.1M7.48%
12/31/2023$ 629.6M$ 71.67M11.38%
9/30/2023$ 583.78M$ 46.52M7.97%
6/30/2023$ 469.59M$ 5.81M1.24%
3/31/2023$ 402.43M$ 5.87M1.46%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) Intang. to Assets stands at 0.44%.
  • Over the past 5 years, COHERUS ONCOLOGY INC's average Intang. to Assets has been 4.65%.
  • The median Intang. to Assets for COHERUS ONCOLOGY INC during this period was 1.24%
  • COHERUS ONCOLOGY INC reached its highest Intang. to Assets over the past 5 years at 14.28%.
  • The lowest Intang. to Assets recorded by COHERUS ONCOLOGY INC in the same timeframe 0.42%

COHERUS ONCOLOGY INC's Intang. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Intang. to Assets Benchmarks
CompanyIntang. to Assets
MGNX : MACROGENICS INC 0%IGMS : IGM BIOSCIENCES INC 0%STRO : SUTRO BIOPHARMA INC 0%AGEN : AGENUS INC 14.74%ATRA : ATARA BIOTHERAPEUTICS INC 0%CELU : CELULARITY INC 13.18%CSBR : CHAMPIONS ONCOLOGY INC 1.1%KPTI : KARYOPHARM THERAPEUTICS INC 0%IPSC : CENTURY THERAPEUTICS INC 12.01%IVVD : INVIVYD INC 0%

Definition of Goodwill & Intangibles to Assets Ratio

[Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for COHERUS ONCOLOGY INC is calculated as follows: Intangibles [ $ 3.56M ] / Assets [ $ 803.73M ]
(=) Intang. to Assets [ 0.44% ]

CHRS - Goodwill & Intangibles to Assets Ratio, Last 5 years

0.42%

Minimum

Dec 31, 2020

14.28%

Maximum

Mar 31, 2025

4.65%

Average

1.24%

Median

Intang. to Assets Benchmark Analysis

The chart above depicts the distribution of Intang. to Assets for companies in the Total Stock Market. The average Intang. to Assets of the companies is 3.98% with a standard deviation of 6.08%.
The following table provides additional summary stats:
Intang. to Assets in the Market:
filtered constituents3.23K
min0%
max23.1%
average3.98%
median0.51%
std6.08%